arrow
A

Agostino Chiaravalloti

Department of Biomedicine and Prevention
H指数:30
被引数:3,251

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Plasma phosphorylated tau biomarkers map onto [^18F]FDG PET hypometabolism: a voxel-wise study in a clinical cohort with CSF-confirmed AD subgroup analysis

血浆磷酸化tau生物标志物与[^18F]FDG PET低代谢区域相关:一项在临床队列中进行的体素级研究,包含脑脊液确诊AD亚组分析

2026-05-270
OAAI
Semiquantitative SSTR PET metrics show molecular–morphologic discordance after 177Lu-DOTATATE in gastroenteropancreatic neuroendocrine neoplasms: an exploratory paired target-lesion analysis

半定量SSTR PET指标显示177Lu-DOTATATE治疗后胃肠胰神经内分泌肿瘤分子-形态学不一致:一项探索性配对靶病灶分析

2026-05-180
OAAI
Presynaptic dopaminergic imaging as a neurodegeneration staging biomarker in the alpha-synucleinopathy continuum

突触前多巴胺能成像作为α-突触核蛋白病连续谱系中神经退行性变的分期生物标志物

2026-04-010
OAAI
18F-FDG PET/CT: bicuspid aortic valve patients' underestimated ally. A systematic review

18F-FDG PET/CT:二叶主动脉瓣患者的被低估的盟友。一项系统综述

2025-12-010
PRE
Role of 2-[18F]FDG-PET as a biomarker of upper motor neuron involvement in amyotrophic lateral sclerosis

2-[18F]FDG-PET作为上运动神经元在肌萎缩侧索硬化症中受累的生物标志物的角色

2025-11-170
OAAI
Progression trajectories from prodromal to overt synucleinopathies: a longitudinal, multicentric brain [18F]FDG-PET study

从前驱到明显的突触核蛋白病的发展轨迹: 一项纵向,多中心的大脑 [18F] fdg-pet研究

2024-10-250
OAAI
Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy
2024-03-1113
OAAI
Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer's disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study

淀粉样蛋白-βeta 42,淀粉样蛋白-βeta 40和淀粉样蛋白-βeta 42/40与可溶性磷酸化tau和阿尔茨海默氏病疾病负担之间的不同关联: 脑脊液和氟脱氧葡萄糖-正电子发射断层扫描研究

2023-08-305
OAAI